We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$327M
AUM Growth
+$27M
Cap. Flow
+$13.4M
Cap. Flow %
4.11%
Top 10 Hldgs %
10.9%
Holding
283
New
46
Increased
97
Reduced
61
Closed
49

Top Sells

Rank Stock Value
1
GDOT icon
Green Dot
GDOT
+$4.11M
2
WOLF icon
Wolfspeed
WOLF
+$3.27M
3
BC icon
Brunswick
BC
+$3.16M
4
UCB
United Community Banks
UCB
+$3.13M
5
LPX icon
Louisiana-Pacific
LPX
+$2.8M

Sector Composition

Rank Sector Weight
1 Financials 20.23%
2 Industrials 16.56%
3 Real Estate 13.09%
4 Technology 10.37%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
201
Manhattan Associates
MANH
$11.5B
$335K 0.1%
7,120
-1,350
-16% -$59.7K
AEIS icon
202
Advanced Energy
AEIS
$13.1B
$334K 0.1%
5,750
+210
+4% +$13.3K
ALK icon
203
Alaska Air
ALK
$5.65B
$332K 0.1%
5,490
MEI icon
204
Methode Electronics
MEI
$593M
$320K 0.1%
7,950
-1,450
-15% -$59.2K
ACLS icon
205
Axcelis
ACLS
$4.26B
$314K 0.1%
+15,860
New +$349K
INCY icon
206
Incyte
INCY
$24.4B
$314K 0.1%
+4,690
New +$321K
ARRY
207
DELISTED
Array Biopharma Inc
ARRY
$313K 0.1%
18,660
-3,430
-16% -$54.6K
HOG icon
208
Harley-Davidson
HOG
$2.72B
$312K 0.1%
7,420
CASS icon
209
Cass Information Systems
CASS
$742M
$310K 0.09%
+5,400
New +$284K
MIK
210
DELISTED
Michaels Stores, Inc
MIK
$307K 0.09%
+16,000
New +$304K
SFLY
211
DELISTED
Shutterfly, Inc.
SFLY
$303K 0.09%
+3,370
New +$303K
BID
212
DELISTED
Sotheby's
BID
$302K 0.09%
+5,550
New +$307K
ANIP icon
213
ANI Pharmaceuticals
ANIP
$1.73B
$298K 0.09%
4,460
-880
-16% -$54.9K
SSTK icon
214
Shutterstock
SSTK
$218M
$296K 0.09%
6,240
-1,130
-15% -$53.7K
SNBR
215
DELISTED
Sleep Number
SNBR
$281K 0.09%
+9,690
New +$295K
BFX
216
DELISTED
BowFlex Inc.
BFX
$278K 0.09%
+17,720
New +$269K
XNCR icon
217
Xencor
XNCR
$1.55B
$265K 0.08%
7,170
-1,250
-15% -$43.1K
CCXI
218
DELISTED
ChemoCentryx, Inc.
CCXI
$255K 0.08%
19,360
-3,600
-16% -$43.1K
CAR icon
219
Avis
CAR
$4.99B
$252K 0.08%
7,760
-1,430
-16% -$62.3K
CNSL
220
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$251K 0.08%
20,301
+3,560
+21% +$41.5K
CBRL icon
221
Cracker Barrel
CBRL
$1.3B
$250K 0.08%
1,600
-280
-15% -$45.2K
MYOK
222
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$245K 0.08%
4,930
-860
-15% -$41.6K
IPGP icon
223
IPG Photonics
IPGP
$3.83B
$236K 0.07%
1,070
CTMX icon
224
CytomX Therapeutics
CTMX
$740M
$229K 0.07%
10,000
-1,820
-15% -$46.5K
NKTR icon
225
Nektar Therapeutics
NKTR
$2.56B
$223K 0.07%
+304
New +$351K

Similar funds

Piermont Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Piermont Capital Management held 283 positions worth $327M, up 9% from $300M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Piermont Capital Management deployed $13.4M of net new capital in Q2 2018, opening 46 new positions and adding to 97 existing holdings. Its largest new stake was The Aaron's Company Inc Class A: 69,190 shares worth $3.01M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Industrials and Real Estate.

On the sell side, the largest reduction was Louisiana-Pacific, an estimated $2.8M trimmed.

  • Piermont Capital Management's largest Q2 2018 buy was The Aaron's Company Inc Class A: 69,190 shares worth $3.01M.
  • Piermont Capital Management added most to Stepan Co in Q2 2018, an estimated $2.48M increase.
  • Piermont Capital Management's biggest Q2 2018 reduction was Louisiana-Pacific, cutting an estimated $2.8M.
  • Piermont Capital Management fully exited Green Dot in Q2 2018, selling an estimated $4.11M.
  • Piermont Capital Management's ten largest holdings make up 11% of its $327M portfolio in Q2 2018.
  • Piermont Capital Management opened 46 new positions and closed 49 in Q2 2018.
  • Piermont Capital Management's portfolio value rose 9% quarter-over-quarter to $327M.

Based on Piermont Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.